MP Evans (MPE): The valuation genie is out of the bottle (BUY) |4imprint (FOUR): Organic growth on track, target price raised (BUY) |Avacta * (AVCT): CAR-T collaboration with Memorial Sloan Kettering Cancer Centre, US (CORP)
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Author:
Guy Hewett | Mark Brewer | Cavendish Research
Pages:
5
MP Evans (MPE): The valuation genie is out of the bottle (BUY) |4imprint (FOUR): Organic growth on track, target price raised (BUY) |Avacta * (AVCT): CAR-T collaboration with Memorial Sloan Kettering Cancer Centre, US (CORP)
